Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00133601 · ClinicalTrials.gov registry record · Phase 1

Cognitive Behavioral Therapy for Insomnia in Chronic Pain Patients

A Phase 1 study of Chronic Pain and Insomnia, sponsored by National Institute of Nursing Research (NINR).

Completed
Registry status
Phase 1
Development phase
28
Enrollment target
1
Study location

NCT00133601: Completed Phase 1 study of Chronic Pain and Insomnia, sponsored by National Institute of Nursing Research (NINR).

NCT00133601 is a Phase 1 study of Chronic Pain and Insomnia that has completed, run by National Institute of Nursing Research (NINR). The registered enrollment target is 28 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00133601, a Phase 1 study of Chronic Pain and Insomnia, has completed, sponsored by National Institute of Nursing Research (NINR).

COMPLETED
Registry status
Phase 1
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

This study of cognitive behavioral therapy for insomnia in chronic pain patients is a randomized, controlled clinical trial of parallel groups with three and six months follow up.

Conditions Studied

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy

Study Locations (1)

New York

  • University of Rochester Neurophysiology and Sleep Research Laboratory - Rochester

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2004-10
Est. Completion 2008-10
Phase Phase 1

What the finished NCT00133601 record still lists

NCT00133601 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (96% lower).

The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Behavioral Therapy is the first listed.

NCT00133601 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT00133601 about?

NCT00133601 is a clinical study titled "Cognitive Behavioral Therapy for Insomnia in Chronic Pain Patients". This study of cognitive behavioral therapy for insomnia in chronic pain patients is a randomized, controlled clinical trial of parallel groups with three and six months follow up.

What is the current status of trial NCT00133601?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2004-10. Estimated completion is 2008-10.

What conditions does trial NCT00133601 study?

This clinical trial studies the following conditions: Chronic Pain, Insomnia.

What interventions are being tested in trial NCT00133601?

The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00133601?

This trial is sponsored by National Institute of Nursing Research (NINR), which has 46 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00133601 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00133601's enrollment target sits among peer trials

28 255th of 301 higher than 47 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00133601, the US trial registry maintained by the National Library of Medicine. NCT00133601 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.